Revision history of "Suggesting promoting vaccination in all treated patients with MS CLASSIFICATION OF EVIDENCE This study provides Class III data that SARSCoV2 mRNA vaccination induces both humoral and cellmediated specific immune responses"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 07:54, 29 February 2024‎ Soundapple47 (Talk | contribs)‎ . . (4,478 bytes) (+4,478)‎ . . (Created page with "compared to HCWs and IFN-β-treated patients. Serum neutralizing activity was present in all the HCWs tested and in only a minority of the fingolimod-treated patients (16.6%)....")
Retrieved from "http://eechcentral.simhq.com/index.php?title=Suggesting_promoting_vaccination_in_all_treated_patients_with_MS_CLASSIFICATION_OF_EVIDENCE_This_study_provides_Class_III_data_that_SARSCoV2_mRNA_vaccination_induces_both_humoral_and_cellmediated_specific_immune_responses"